PCOS at menopause

Professor Helena Teede


Polycystic ovary syndrome affects around 13% of women and is a reproductive, metabolic and psychological disorder. Diagnosis is based on 2 out of 3 features including hyperandrogenism, oligoovulation and polycystic ovarian morphology on ultrasound. There is limited evidence on the long-term natural history of the condition, however long term metabolic sequelae are clear. Ovulatory function approaching menopause, age of menopause, clinical features at midlife and beyond will be discussed.


Professor Helena Teede, MBBS PhD FRACP FAAHMS FRANZCOG, is Executive Director Monash Partners Academic Health Science Centre, an NHMRC Practitioner Fellow, Professor of Women’s Health and Director Monash Centre for Health Research and Implementation, School Public Health, Monash University, Chair of the National Women’s Health Research, Translation and Impact Network

Lead NHMRC Centre’s Research Excellence on Women’s Health in Reproductive Life (including menopause, PCOS and Infertility)and CIA on the CRE in PCOS, co-lead on CRE in Healthy Preconception, Pregnancy and Postpartum. She is an Endocrinologist Monash Health and in 2021 became an honorary fellow of RANZCOG and received an International Laureate award from the US Endocrine Society.